
What is Tirzepatide?
Tirzepatide is a once-weekly injectable medication containing the same active ingredient as Mounjaro®. It’s a GLP-1 and GIP receptor agonist that works by regulating appetite, slowing digestion, and supporting your body’s insulin response, which aids in weight loss and better metabolic health.

What is Compounded Tirzepatide?
Compounded Tirzepatide is a custom-made version of the FDA-approved medication, created by licensed compounding pharmacies. While these medications adhere to strict quality standards and regulations, they are not FDA-approved or evaluated for safety or effectiveness.
How Does It Work?
Tirzepatide works by:
- Reducing hunger and curbing cravings.
- Helping you feel fuller longer by slowing digestion.
- Supporting your natural insulin response to improve metabolic health.
What to Expect:
- Simple, once-weekly injections.
- Gradual, sustainable weight loss.
- Enhanced energy and reduced cravings.
Evidence of Effectiveness:
Research shows that individuals taking Mounjaro (Tirzepatide) had superior weight loss results compared to those taking Semaglutide:
- 3 times as likely to lose 15% or more of their total body weight.
- 2.5 times as likely to experience 10% or more weight loss.
- 1.8 times as likely to experience 5% or more weight loss compared to those taking Semaglutide, the active ingredient in Ozempic®.

Why
Choose Nova Health?
With Nova Health, you get direct access to Dr. Kelley for questions or concerns, no insurance required, and no long-term commitments. Medications ship free within 1-4 days of prescription approval.
Frequently Asked Questions
GET STARTED TODAYTirzepatide is the active ingredient in Mounjaro®. It is a GLP-1 and GIP receptor agonist that helps manage appetite, support weight loss, and improve metabolic health by regulating insulin responses in your body.
No, Nova Health doesn’t require insurance. We offer clear and simple pricing, along with affordable medication options, making it easy and accessible to take care of your health.
Evidence shows that individuals taking Mounjaro (Tirzepatide) were:
- 3 times as likely to lose 15% or more of their total body weight.
- 2.5 times as likely to experience 10% or more weight loss.
- 1.8 times as likely to experience 5% or more weight loss, compared to those taking Semaglutide, the active ingredient found in Ozempic®.
Absolutely! We understand that circumstances may change. There are no long-term contracts or cancellation fees involved. We are committed to customer satisfaction.